Discovery of novel BTK inhibitors with carboxylic acids.
Bioorg Med Chem Lett
; 27(6): 1471-1477, 2017 03 15.
Article
in En
| MEDLINE
| ID: mdl-28254166
ABSTRACT
We report the design and synthesis of a series of novel Bruton's Tyrosine Kinase (BTK) inhibitors with a carboxylic acid moiety in the ribose pocket. This series of compounds has demonstrated much improved off-target selectivities including adenosine uptake (AdU) inhibition compared to the piperidine amide series. Optimization of the initial lead compound 4 based on BTK enzyme inhibition, and human peripheral blood mononuclear cell (hPBMC) and human whole blood (hWB) activity led to the discovery of compound 40, with potent BTK inhibition, reduced off target activities, as well as favorable pharmacokinetic profile in both rat and dog.
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Protein-Tyrosine Kinases
/
Carboxylic Acids
/
Protein Kinase Inhibitors
/
Drug Discovery
Limits:
Animals
/
Humans
Language:
En
Year:
2017
Type:
Article